DexCom Net Cash Flow 2010-2025 | DXCM

DexCom net cash flow for the twelve months ending June 30, 2025 was $0.947B, a 62.18% increase year-over-year.

  • DexCom annual net cash flow for 2024 was $0.04B, a 152.51% decline from 2023.
  • DexCom annual net cash flow for 2023 was $-0.076B, a 81.53% decline from 2022.
  • DexCom annual net cash flow for 2022 was $-0.41B, a 274.3% decline from 2021.

DexCom Net Cash Flow 2010-2025 | DXCM

  • DexCom annual net cash flow for 2024 was $0.04B, a 152.51% decline from 2023.
  • DexCom annual net cash flow for 2023 was $-0.076B, a 81.53% decline from 2022.
  • DexCom annual net cash flow for 2022 was $-0.41B, a 274.3% decline from 2021.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$186.1B
Intuitive Surgical (ISRG)$169.7B
IDEXX Laboratories (IDXX)$51.8B
Edwards Lifesciences (EW)$47.8B
Alcon (ALC)$39.4B
IQVIA Holdings (IQV)$32.4B
Mettler-Toledo (MTD)$26.8B
STERIS (STE)$24.1B
Waters (WAT)$18B
SONOVA HOLDING (SONVY)$17.4B
Hologic (HOLX)$14.9B
Penumbra (PEN)$10.6B
Globus Medical (GMED)$8.3B
Sysmex ADR (SSMXY)$7.9B
Masimo (MASI)$7.6B
Teleflex (TFX)$5.6B
Glaukos (GKOS)$5.5B
TransMedics (TMDX)$3.9B
Integer Holdings (ITGR)$3.8B
LivaNova (LIVN)$3.1B
Veracyte (VCYT)$2.4B
Alphatec Holdings (ATEC)$2.4B
PROCEPT BioRobotics (PRCT)$2.2B
Artivion (AORT)$2.1B
Nihon Kohden (NHNKY)$2B
Elekta AB (EKTAY)$1.8B
Integra LifeSciences Holdings (IART)$1.2B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B
Pulse Biosciences (PLSE)$1B